Literature DB >> 29029114

Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2.

David M Arana1,2, Adriana Ortega2,3, Eva González-Barberá4, Noelia Lara2,3, Verónica Bautista2,3, Dolores Gómez-Ruíz4, David Sáez2,3, Sara Fernández-Romero2,3, Belén Aracil2,3, María Pérez-Vázquez2,3, José Campos2,3, Jesús Oteo2,3.   

Abstract

OBJECTIVES: There is little information about carbapenemase-producing (CP) Citrobacter spp. We studied the molecular epidemiology and microbiological features of CP Citrobacter spp. isolates collected in Spain (2013-15).
METHODS: In total, 119 isolates suspected of being CP by the EUCAST screening cut-off values were analysed. Carbapenemases and ESBLs were characterized using PCR and sequencing. The genetic relationship among Citrobacter freundii isolates was studied by PFGE.
RESULTS: Of the 119 isolates, 63 (52.9%) produced carbapenemases, of which 37 (58.7%) produced VIM-1, 20 (31.7%) produced OXA-48, 12 (19%) produced KPC-2, 2 (3.2%) produced NDM-1 and 1 (1.6%) produced VIM-2; 9 C. freundii isolates co-produced VIM-1 plus OXA-48. Fourteen isolates (22.2%) also carried ESBLs: 8 CTX-M-9 plus SHV-12, 2 CTX-M-9, 2 SHV-12 and 2 CTX-M-15. Fifty-seven isolates (90.5%) were C. freundii, 4 (6.3%) were Citrobacter koseri, 1 (1.6%) was Citrobacter amalonaticus and 1 (1.6%) was Citrobacter braakii. By EUCAST breakpoints, eight (12.7%) of the CP isolates were susceptible to the four carbapenems tested. In the 53 CP C. freundii analysed by PFGE, a total of 44 different band patterns were observed. Four PFGE clusters were identified: cluster 1 included eight isolates co-producing VIM-1 and OXA-48; blaVIM-1 was carried in a class 1 integron (intI-blaVIM-1-aacA4-dfrB1-aadA1-catB2-qacEΔ1/sul1) and blaOXA-48 was carried in a Tn1999.2 transposon.
CONCLUSIONS: We observed the clonal and polyclonal spread of CP Citrobacter spp. across several Spanish geographical areas. Four species of Citrobacter spp. produced up to five carbapenemase types, including co-production of VIM-1 plus OXA-48. Some CP Citrobacter spp. isolates were susceptible to the four carbapenems tested, a finding with potential clinical implications.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29029114     DOI: 10.1093/jac/dkx325

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

1.  Characterization of Carbapenemase-Producing Klebsiella oxytoca in Spain, 2016-2017.

Authors:  María Pérez-Vazquez; Jesús Oteo-Iglesias; Pedro J Sola-Campoy; Hugo Carrizo-Manzoni; Verónica Bautista; Noelia Lara; Belén Aracil; Almudena Alhambra; Luis Martínez-Martínez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 2.  Past and Present Perspectives on β-Lactamases.

Authors:  Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 3.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

4.  Dissemination of Carbapenemases (OXA-48, NDM and VIM) Producing Enterobacteriaceae Isolated from the Mohamed VI University Hospital in Marrakech, Morocco.

Authors:  Souad Loqman; Nabila Soraa; Seydina M Diene; Jean-Marc Rolain
Journal:  Antibiotics (Basel)       Date:  2021-04-26

5.  Clinical and Genomic Epidemiology of Carbapenem-Nonsusceptible Citrobacter spp. at a Tertiary Health Care Center over 2 Decades.

Authors:  Ahmed Babiker; Daniel R Evans; Marissa P Griffith; Christi L McElheny; Mohamed Hassan; Lloyd G Clarke; Roberta T Mettus; Lee H Harrison; Yohei Doi; Ryan K Shields; Daria Van Tyne
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

6.  Draft Genome Sequences of Citrobacter freundii and Citrobacter murliniae Strains Isolated from the Feces of Preterm Infants.

Authors:  Yuhao Chen; Thomas C Brook; Cristina Alcon-Giner; Paul Clarke; Lindsay J Hall; Lesley Hoyles
Journal:  Microbiol Resour Announc       Date:  2019-08-15

7.  Genomic characterization of Citrobacter freundii strains coproducing OXA-48 and VIM-1 carbapenemase enzymes isolated in leukemic patient in Spain.

Authors:  Rym Lalaoui; Ana Djukovic; Sofiane Bakour; Linda Hadjadj; Jaime Sanz; Miguel Salavert; Jose Luis López-Hontangas; Miguel A Sanz; Carles Ubeda; Jean-Marc Rolain
Journal:  Antimicrob Resist Infect Control       Date:  2019-10-29       Impact factor: 4.887

Review 8.  Gene Transmission in the One Health Microbiosphere and the Channels of Antimicrobial Resistance.

Authors:  Fernando Baquero; Teresa M Coque; José-Luis Martínez; Sonia Aracil-Gisbert; Val F Lanza
Journal:  Front Microbiol       Date:  2019-12-17       Impact factor: 5.640

9.  Citrobacter freundii fitness during bloodstream infection.

Authors:  Mark T Anderson; Lindsay A Mitchell; Lili Zhao; Harry L T Mobley
Journal:  Sci Rep       Date:  2018-08-07       Impact factor: 4.379

10.  Early OXA-48-Producing Enterobacterales Isolates Recovered in a Spanish Hospital Reveal a Complex Introduction Dominated by Sequence Type 11 (ST11) and ST405 Klebsiella pneumoniae Clones.

Authors:  Desirèe Gijón; Ana P Tedim; Aránzazu Valverde; Irene Rodríguez; María-Isabel Morosini; Teresa M Coque; Marina Manrique; Eduardo Pareja; Raquel Tobes; Patricia Ruiz-Garbajosa; Rafael Cantón
Journal:  mSphere       Date:  2020-04-08       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.